These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [T and B lymphocytes in the spleen of patients with Hodgkin's disease]. Pluzańska A; Robak T; Kabza R; Szadowska A; Mazurowa A Pol Arch Med Wewn; 1976 Jul; 56(7):55-64. PubMed ID: 1084992 [No Abstract] [Full Text] [Related]
27. Impairment in cellular protein phosphorylation by mitogen activated lymphocytes from patients with Hodgkin's disease. Damle RN; Gangal SG; Advani SH Indian J Med Res; 1992 Aug; 96():230-5. PubMed ID: 1428061 [TBL] [Abstract][Full Text] [Related]
28. [Immunological characteristics of the peripheral blood and lymph node lymphocytes in Hodgkin's disease and reactive lymphadenitis]. Loginskiĭ VE; Polishchuk RS; Logoĭda DM Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):35-8. PubMed ID: 6969399 [No Abstract] [Full Text] [Related]
29. Letter: T lymphocytes and Reed-Sternberg cells in spleen of Hodgkin's disease. Belpomme D; Joseph R; Navares L; Gerard-Marchant R; Huchet R; Botto I; Grandjon D; Mathé G N Engl J Med; 1974 Dec; 291(26):1417. PubMed ID: 4547826 [No Abstract] [Full Text] [Related]
30. T and B spleen lymphocytes in Hodgkin's disease. Santoro A; Belpomme D; Mathe G Haematologica; 1977 Feb; 62(1):11-22. PubMed ID: 404218 [No Abstract] [Full Text] [Related]
31. [Membrane immunoglobulins in peripheral blood lymphocytes in Hodgkin's disease]. Grifoni V; Del Giacco GS; Manconi PE; Tognella S Haematologica; 1972; 57(9):529-32. PubMed ID: 4199306 [No Abstract] [Full Text] [Related]
32. Lymphocyte reactivity in Hodgkin's disease: a lymphocyte civil war. DeVita VT N Engl J Med; 1973 Oct; 289(15):801-2. PubMed ID: 4542305 [No Abstract] [Full Text] [Related]
33. [Effect of cytotoxic Hodgkin's serum on LIF activity of T- and B-lymphocytes]. Chisesi T; Giacobbo M; Capnist T Boll Ist Sieroter Milan; 1978 Sep; 57(4):428-33. PubMed ID: 310684 [TBL] [Abstract][Full Text] [Related]
34. [Immunology of Hodgkin's disease. Facts and considerations]. Griffoni V; Del Giacco GS; Tognella S; Mantovani G; Manconi PE Recenti Prog Med; 1974 May; 56(5):392-7. PubMed ID: 4546622 [No Abstract] [Full Text] [Related]
35. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease]. Pluzańska A Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871 [No Abstract] [Full Text] [Related]
36. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants. Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498 [TBL] [Abstract][Full Text] [Related]
37. [Hodgkin's disease from the standpoint of immunology]. Kuroyanagi T; Hosokawa Z; Sukigara M Nihon Rinsho; 1974 Jun; 32(6):1213-20. PubMed ID: 4610217 [No Abstract] [Full Text] [Related]
38. [Hodgkin's disease--immunological aspects]. Plat M; Frank KH; Fleischer J; Plat U; Koslowski R Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835 [TBL] [Abstract][Full Text] [Related]
39. Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease. Damle RN; Tatake RJ; Advani SH; Gangal SG Br J Cancer; 1990 Mar; 61(3):404-6. PubMed ID: 2328206 [No Abstract] [Full Text] [Related]
40. [The character and function of mononuclear cells in the spleen and peripheral blood in Hodgkin's disease]. Pick AI; Loven D; Douer D; Kessler H; Weiss H; Duczyminer M; Har-Zahav L Harefuah; 1980; 98(10):433-7. PubMed ID: 7005036 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]